Published in J Neurosci on November 16, 2011
Decision Making Study in Young and Middle-Aged Adults: Part II (DND) | NCT03512171
The mysterious motivational functions of mesolimbic dopamine. Neuron (2012) 3.22
Dopaminergic mechanisms of individual differences in human effort-based decision-making. J Neurosci (2012) 1.64
Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia. J Abnorm Psychol (2012) 1.63
A review of reward processing and motivational impairment in schizophrenia. Schizophr Bull (2013) 1.52
Mesolimbic dopamine signals the value of work. Nat Neurosci (2015) 1.27
Effort, anhedonia, and function in schizophrenia: reduced effort allocation predicts amotivation and functional impairment. J Abnorm Psychol (2014) 1.25
Parsing Anhedonia: Translational Models of Reward-Processing Deficits in Psychopathology. Curr Dir Psychol Sci (2013) 1.14
Impaired effort allocation in patients with schizophrenia. Schizophr Res (2014) 0.99
Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers. Front Neurosci (2013) 0.97
Adults with autism spectrum disorders exhibit decreased sensitivity to reward parameters when making effort-based decisions. J Neurodev Disord (2012) 0.96
Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia. Neurosci Biobehav Rev (2013) 0.95
Reward Pays the Cost of Noise Reduction in Motor and Cognitive Control. Curr Biol (2015) 0.95
Cognitive effort: A neuroeconomic approach. Cogn Affect Behav Neurosci (2015) 0.92
Reconceptualizing anhedonia: novel perspectives on balancing the pleasure networks in the human brain. Front Behav Neurosci (2015) 0.91
Towards a second-person neuropsychiatry. Philos Trans R Soc Lond B Biol Sci (2016) 0.91
Dopamine antagonism decreases willingness to expend physical, but not cognitive, effort: a comparison of two rodent cost/benefit decision-making tasks. Neuropsychopharmacology (2014) 0.89
Dopamine and food addiction: lexicon badly needed. Biol Psychiatry (2012) 0.88
Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task. Psychopharmacology (Berl) (2013) 0.87
Caudate responses to reward anticipation associated with delay discounting behavior in healthy youth. Dev Cogn Neurosci (2013) 0.87
Lipopolysaccharide Alters Motivated Behavior in a Monetary Reward Task: a Randomized Trial. Neuropsychopharmacology (2016) 0.85
Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms. Int J Neuropsychopharmacol (2014) 0.84
A new approach to assess gambling-like behavior in laboratory rats: using intracranial self-stimulation as a positive reinforcer. Front Behav Neurosci (2014) 0.83
Translational Assessment of Reward and Motivational Deficits in Psychiatric Disorders. Curr Top Behav Neurosci (2016) 0.82
Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. J Neurosci (2013) 0.82
Impulsive actions and choices in laboratory animals and humans: effects of high vs. low dopamine states produced by systemic treatments given to neurologically intact subjects. Front Behav Neurosci (2014) 0.82
Sleep Deprivation Impairs and Caffeine Enhances My Performance, but Not Always Our Performance. Pers Soc Psychol Rev (2016) 0.82
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine. Neuropsychopharmacology (2016) 0.81
Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans. Psychopharmacology (Berl) (2012) 0.81
Dopamine enhances willingness to exert effort for reward in Parkinson's disease. Cortex (2015) 0.80
Neural correlates of motor vigour and motor urgency during exercise. Sports Med (2013) 0.80
Making sense: Dopamine activates conscious self-monitoring through medial prefrontal cortex. Hum Brain Mapp (2015) 0.80
Caffeine increases psychomotor performance on the effort expenditure for rewards task. Pharmacol Biochem Behav (2012) 0.78
The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion. Psychopharmacology (Berl) (2014) 0.78
The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs. PLoS One (2014) 0.78
Enhancement stimulants: perceived motivational and cognitive advantages. Front Neurosci (2013) 0.77
Adaptive effort investment in cognitive and physical tasks: a neurocomputational model. Front Behav Neurosci (2015) 0.77
Trait Anticipatory Pleasure Predicts Effort Expenditure for Reward. PLoS One (2015) 0.77
Altering Effort Costs in Parkinson's Disease with Noninvasive Cortical Stimulation. J Neurosci (2015) 0.76
Measuring anhedonia: impaired ability to pursue, experience, and learn about reward. Front Psychol (2015) 0.76
A specific role for serotonin in overcoming effort cost. Elife (2016) 0.76
Avolition in schizophrenia is associated with reduced willingness to expend effort for reward on a Progressive Ratio task. Schizophr Res (2015) 0.76
Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses. Psychopharmacology (Berl) (2016) 0.76
The human subthalamic nucleus encodes the subjective value of reward and the cost of effort during decision-making. Brain (2016) 0.76
Asymmetric frontal cortical activity predicts effort expenditure for reward. Soc Cogn Affect Neurosci (2014) 0.76
Struggling toward reward: Recent experience of anhedonia interacts with motivation to predict reward pursuit in the face of a stressful manipulation. PLoS One (2017) 0.75
Adult age differences in decision making across domains: Increased discounting of social and health-related rewards. Psychol Aging (2016) 0.75
Beyond Sensation Seeking: A Conceptual Framework for Individual Differences in Psychostimulant Drug Effects in Healthy Humans. Curr Opin Behav Sci (2017) 0.75
Receipt of reward leads to altered estimation of effort. Proc Natl Acad Sci U S A (2015) 0.75
Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder. J Subst Abuse Treat (2016) 0.75
Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat. Psychopharmacology (Berl) (2015) 0.75
What Makes You Go Faster?: The Effect of Reward on Speeded Action under Risk. Front Psychol (2017) 0.75
Vicarious Effort-Based Decision-Making in Autism Spectrum Disorders. J Autism Dev Disord (2017) 0.75
Frontal theta accounts for individual differences in the cost of conflict on decision making. Brain Res (2017) 0.75
Longitudinal data analysis for discrete and continuous outcomes. Biometrics (1986) 60.93
Dissociating the role of the orbitofrontal cortex and the striatum in the computation of goal values and prediction errors. J Neurosci (2008) 5.64
The neurobiology of decision: consensus and controversy. Neuron (2009) 4.77
Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology (Berl) (2007) 4.73
Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking. Nature (2011) 4.58
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry (2004) 3.80
Separate neural pathways process different decision costs. Nat Neurosci (2006) 3.69
Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev (2010) 3.46
Variability in nucleus accumbens activity mediates age-related suboptimal financial risk taking. J Neurosci (2010) 3.01
Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology (2002) 2.55
Weighing up the benefits of work: behavioral and neural analyses of effort-related decision making. Neural Netw (2006) 2.33
Dopaminergic modulation of risk-based decision making. Neuropsychopharmacology (2008) 2.18
Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats. Psychopharmacology (Berl) (2000) 2.16
Dopaminergic and glutamatergic regulation of effort- and delay-based decision making. Neuropsychopharmacology (2007) 2.11
Delays conferred by escalating costs modulate dopamine release to rewards but not their predictors. J Neurosci (2010) 2.07
Calculating utility: preclinical evidence for cost-benefit analysis by mesolimbic dopamine. Psychopharmacology (Berl) (2006) 2.03
Neural computations underlying action-based decision making in the human brain. Proc Natl Acad Sci U S A (2009) 1.98
Separate valuation subsystems for delay and effort decision costs. J Neurosci (2010) 1.97
Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav (2002) 1.94
Worth the 'EEfRT'? The effort expenditure for rewards task as an objective measure of motivation and anhedonia. PLoS One (2009) 1.93
Dopamine, behavioral economics, and effort. Front Behav Neurosci (2009) 1.91
Separate neural mechanisms underlie choices and strategic preferences in risky decision making. Neuron (2009) 1.77
Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology (Berl) (1991) 1.65
Differential involvement of serotonin and dopamine systems in cost-benefit decisions about delay or effort. Psychopharmacology (Berl) (2004) 1.58
Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease? Neuropsychopharmacology (2009) 1.51
Nucleus accumbens dopamine depletions make animals highly sensitive to high fixed ratio requirements but do not impair primary food reinforcement. Neuroscience (2001) 1.50
Choosing to make an effort: the role of striatum in signaling physical effort of a chosen action. J Neurophysiol (2010) 1.43
Nucleus accumbens dopamine release increases during instrumental lever pressing for food but not free food consumption. Pharmacol Biochem Behav (1994) 1.32
Nucleus accumbens dopamine depletions alter relative response allocation in a T-maze cost/benefit task. Behav Brain Res (1996) 1.30
Dopamine modulates effort-based decision making in rats. Behav Neurosci (2009) 1.29
The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans. Neuropsychopharmacology (2010) 1.28
Prefrontostriatal circuitry regulates effort-related decision making. Cereb Cortex (2009) 1.27
Nucleus accumbens dopamine and work requirements on interval schedules. Behav Brain Res (2002) 1.26
Differential effects of dopaminergic manipulations on risky choice. Psychopharmacology (Berl) (2010) 1.21
Acute phenylalanine/tyrosine depletion reduces motivation to smoke cigarettes across stages of addiction. Neuropsychopharmacology (2011) 1.07
Application of odds ratio regression models for assessing familial aggregation from case-control studies. Am J Epidemiol (1986) 0.98
Perturbations in different forms of cost/benefit decision making induced by repeated amphetamine exposure. Psychopharmacology (Berl) (2009) 0.97
Effects of amphetamine on reactivity to emotional stimuli. Psychopharmacology (Berl) (2011) 0.97
Psychomotor stimulant properties of addictive drugs. Ann N Y Acad Sci (1988) 0.90
Meditation experience is associated with increased cortical thickness. Neuroreport (2005) 4.15
Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev (2010) 3.46
Preference for immediate over delayed rewards is associated with magnitude of ventral striatal activity. J Neurosci (2006) 3.10
Rewarding, stimulant, and sedative alcohol responses and relationship to future binge drinking. Arch Gen Psychiatry (2011) 2.71
Dopaminergic network differences in human impulsivity. Science (2010) 2.49
Biphasic alcohol response differs in heavy versus light drinkers. Alcohol Clin Exp Res (2002) 2.39
Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology (2003) 2.37
The neural correlates of third-party punishment. Neuron (2008) 2.33
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacol (2005) 2.10
Fearful expressions gain preferential access to awareness during continuous flash suppression. Emotion (2007) 2.07
Activation of prefrontal cortex by transcranial direct current stimulation reduces appetite for risk during ambiguous decision making. J Neurosci (2007) 2.05
Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits. Nat Neurosci (2010) 2.01
Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav (2002) 1.94
Attentional rubbernecking: cognitive control and personality in emotion-induced blindness. Psychon Bull Rev (2005) 1.93
Worth the 'EEfRT'? The effort expenditure for rewards task as an objective measure of motivation and anhedonia. PLoS One (2009) 1.93
Behavioral and biological indicators of impulsivity in the development of alcohol use, problems, and disorders. Alcohol Clin Exp Res (2010) 1.87
Acute-alcohol effects on the Experiential Discounting Task (EDT) and a question-based measure of delay discounting. Pharmacol Biochem Behav (2006) 1.83
Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology (2003) 1.65
Dopaminergic mechanisms of individual differences in human effort-based decision-making. J Neurosci (2012) 1.64
Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia. J Abnorm Psychol (2012) 1.63
Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. J Neurosci (2008) 1.55
Relation of obesity to consummatory and anticipatory food reward. Physiol Behav (2009) 1.52
Is there a general factor of prevalent psychopathology during adulthood? J Abnorm Psychol (2012) 1.49
On the scent of human olfactory orbitofrontal cortex: meta-analysis and comparison to non-human primates. Brain Res Brain Res Rev (2005) 1.49
Menstrual cycle phase and responses to drugs of abuse in humans. Drug Alcohol Depend (2006) 1.47
A thalamocorticostriatal dopamine network for psychostimulant-enhanced human cognitive flexibility. Biol Psychiatry (2012) 1.44
Effects of sleep deprivation on impulsive behaviors in men and women. Physiol Behav (2007) 1.44
Incubation of cue-induced cigarette craving during abstinence in human smokers. Biol Psychiatry (2011) 1.44
Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biol Psychiatry (2010) 1.39
Bupropion improves attention but does not affect impulsive behavior in healthy young adults. Exp Clin Psychopharmacol (2008) 1.36
A unique role for the human amygdala in novelty detection. Neuroimage (2010) 1.34
Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology (2005) 1.34
Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers. J Clin Psychopharmacol (2008) 1.34
Test-retest characteristics of the Balloon Analogue Risk Task (BART). Exp Clin Psychopharmacol (2008) 1.32
Anatomical insights into the interaction of emotion and cognition in the prefrontal cortex. Neurosci Biobehav Rev (2011) 1.31
Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences. Nicotine Tob Res (2006) 1.31
Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology (2008) 1.31
Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacology (2006) 1.30
An emotion-induced attentional blink elicited by aversively conditioned stimuli. Emotion (2006) 1.30
Effect of tryptophan depletion on impulsive behavior in men with or without a family history of alcoholism. Behav Brain Res (2002) 1.28
Genetics of caffeine consumption and responses to caffeine. Psychopharmacology (Berl) (2010) 1.27
GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend (2002) 1.27
Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology (Berl) (2009) 1.27
Reward processing dysfunction in major depression, bipolar disorder and schizophrenia. Curr Opin Psychiatry (2015) 1.25
Differential effects of nicotine on alcohol consumption in men and women. Psychopharmacology (Berl) (2006) 1.24
Subjective, behavioral, and physiological effects of acute caffeine in light, nondependent caffeine users. Psychopharmacology (Berl) (2006) 1.24
The drug effects questionnaire: psychometric support across three drug types. Psychopharmacology (Berl) (2012) 1.22
Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. Exp Clin Psychopharmacol (2009) 1.21
Effects of morphine and naltrexone on impulsive decision making in rats. Psychopharmacology (Berl) (2004) 1.21
Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking. Psychopharmacology (Berl) (2012) 1.21
Mecamylamine attenuates the subjective stimulant-like effects of alcohol in social drinkers. Alcohol Clin Exp Res (2003) 1.20
Personality and the subjective effects of acute amphetamine in healthy volunteers. Neuropsychopharmacology (2006) 1.19
Hormonal, cardiovascular, and subjective responses to acute stress in smokers. Psychopharmacology (Berl) (2008) 1.19
Amphetamine-induced place preference in humans. Biol Psychiatry (2008) 1.17
Sustained amygdala response to both novel and newly familiar faces characterizes inhibited temperament. Soc Cogn Affect Neurosci (2010) 1.17
Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13). PLoS One (2012) 1.14
Catechol-O-methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine. Psychiatr Genet (2010) 1.11
Nucleus accumbens lesions decrease sensitivity to rapid changes in the delay to reinforcement. Behav Brain Res (2006) 1.10
Candidate gene studies of a promising intermediate phenotype: failure to replicate. Neuropsychopharmacology (2012) 1.08
The combined effects of alcohol, caffeine, and expectancies on subjective experience, impulsivity, and risk-taking. Exp Clin Psychopharmacol (2013) 1.08
Amygdala temporal dynamics: temperamental differences in the timing of amygdala response to familiar and novel faces. BMC Neurosci (2009) 1.06
Effects of acute psychosocial stress on cigarette craving and smoking. Nicotine Tob Res (2010) 1.06
Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana. Exp Clin Psychopharmacol (2009) 1.05
Cue-reactors: individual differences in cue-induced craving after food or smoking abstinence. PLoS One (2010) 1.05
Diazepam impairs behavioral inhibition but not delay discounting or risk taking in healthy adults. Exp Clin Psychopharmacol (2006) 1.05
Differential effects of ethanol on serum GABAergic 3alpha,5alpha/3alpha,5beta neuroactive steroids in mice, rats, cynomolgus monkeys, and humans. Alcohol Clin Exp Res (2009) 1.04
Endocannabinoid signalling: has it got rhythm? Br J Pharmacol (2010) 1.04
Norepinephrine transporter gene variation modulates acute response to D-amphetamine. Biol Psychiatry (2007) 1.04
Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants. Am J Med Genet B Neuropsychiatr Genet (2005) 1.04
Attenuated cortisol response to alcohol in heavy social drinkers. Int J Psychophysiol (2005) 1.04
Impulsivity and the modular organization of resting-state neural networks. Cereb Cortex (2012) 1.04
Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism. Drug Alcohol Depend (2013) 1.03
Striatal dopamine transmission in healthy humans during a passive monetary reward task. Neuroimage (2007) 1.03
The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers. Drug Alcohol Depend (2002) 1.03
Contextual conditioning enhances the psychostimulant and incentive properties of d-amphetamine in humans. Addict Biol (2011) 1.02
Mecamylamine and ethanol preference in healthy volunteers. Alcohol Clin Exp Res (2005) 1.01
Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans. Neuropsychopharmacology (2012) 1.00
In the company of others: social factors alter acute alcohol effects. Psychopharmacology (Berl) (2013) 1.00
Personality and gender differences in effects of d-amphetamine on risk taking. Exp Clin Psychopharmacol (2007) 1.00
Delay of gratification and delay discounting in rats. Behav Processes (2002) 0.99
Amphetamine as a social drug: effects of d-amphetamine on social processing and behavior. Psychopharmacology (Berl) (2012) 0.99
Lack of association between COMT and working memory in a population-based cohort of healthy young adults. Neuropsychopharmacology (2013) 0.98
Emotion modulation of visual attention: categorical and temporal characteristics. PLoS One (2010) 0.98
Quantifying reinforcement value and demand for psychoactive substances in humans. Curr Drug Abuse Rev (2012) 0.98
Challenges for translational psychopharmacology research--some basic principles. Psychopharmacology (Berl) (2008) 0.97
Therapeutic doses of diazepam do not alter impulsive behavior in humans. Pharmacol Biochem Behav (2004) 0.97
Correlation of individual differences in schizotypal personality traits with amphetamine-induced dopamine release in striatal and extrastriatal brain regions. Am J Psychiatry (2010) 0.97
Effects of amphetamine on reactivity to emotional stimuli. Psychopharmacology (Berl) (2011) 0.97
Enhanced mood and psychomotor performance by a caffeine-containing energy capsule in fatigued individuals. Exp Clin Psychopharmacol (2008) 0.96
An association study of the brain-derived neurotrophic factor Val66Met polymorphism and amphetamine response. Am J Med Genet B Neuropsychiatr Genet (2006) 0.95
Stress-induced changes in mood and cortisol release predict mood effects of amphetamine. Drug Alcohol Depend (2010) 0.95
Serotonin transporter genotype and acute subjective response to amphetamine. Am J Addict (2006) 0.94
A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects. Schizophr Res (2006) 0.93
Effects of nicotine on attention and inhibitory control in healthy nonsmokers. Exp Clin Psychopharmacol (2011) 0.93
The prescription opioid, oxycodone, does not alter behavioral measures of impulsivity in healthy volunteers. Pharmacol Biochem Behav (2009) 0.93
Control yourself: alcohol and impulsivity. Alcohol Clin Exp Res (2010) 0.93
Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements. Alcohol Clin Exp Res (2012) 0.93